529 filings
Page 4 of 27
8-K
c66e 3lqhj6
8 May 23
Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
4:07pm
DEFA14A
y7w9fqf1u
18 Apr 23
Additional proxy soliciting materials
4:00pm
4
52da2
12 Apr 23
Syndax Pharmaceuticals / Briggs Morrison ownership change
4:03pm
4
j49nmwn2uzsra ct
12 Apr 23
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:02pm
3
zpv5rxulk
12 Apr 23
Syndax Pharmaceuticals / Neil Gallagher ownership change
4:01pm
ARS
30934 gez20p
7 Apr 23
Annual report to shareholders
4:05pm
DEFA14A
q6ocndc6g8qdhuk3z9gu
7 Apr 23
Additional proxy soliciting materials
4:02pm
8-K
vtahloy23 kzj
30 Mar 23
Syndax Pharmaceuticals Announces Appointment of Neil Gallagher, M.D., Ph.D. as President, Head of Research and Development
8:00am
PRE 14A
a9q ttu4q
28 Mar 23
Preliminary proxy
4:15pm
4
jk09dy
14 Mar 23
Syndax Pharmaceuticals / Briggs Morrison ownership change
4:42pm
S-8
eiqh5f9x5156ulkyq6v
28 Feb 23
Registration of securities for employees
4:15pm
8-K
kf7s0
28 Feb 23
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
4:06pm
4
21c3b2qw1if8aldx3g
17 Feb 23
Syndax Pharmaceuticals / Peter Ordentlich ownership change
6:09pm
SC 13G/A
2y95l11iswj
14 Feb 23
Syndax Pharmaceuticals / Nantahala Capital Management ownership change
4:46pm
SC 13G/A
gcgo6x
14 Feb 23
Syndax Pharmaceuticals / Avidity Partners Management ownership change
3:47pm
SC 13G/A
ntef 8aco0zldxyg
14 Feb 23
Syndax Pharmaceuticals / Frazier Life Sciences Public Fund ownership change
12:12pm
SC 13G/A
bgt1 ttboy
14 Feb 23
Syndax Pharmaceuticals / BIOTECHNOLOGY VALUE FUND L P ownership change
11:53am